Cannara Biotech Inc.
LOVE.TO
TSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 63.74% | -69.18% | -18.00% | 27.20% | 38.18% |
| Total Depreciation and Amortization | -15.21% | -30.39% | 80.86% | -21.27% | 1.17% |
| Total Amortization of Deferred Charges | 150.00% | -6.78% | -- | -- | -- |
| Total Other Non-Cash Items | -51.99% | 287.40% | -27.70% | 31.58% | -11.20% |
| Change in Net Operating Assets | -1,592.05% | 96.14% | -165.15% | 173.75% | -2,709.07% |
| Cash from Operations | -62.09% | 176.69% | -79.16% | 654.88% | -142.01% |
| Capital Expenditure | 28.30% | -209.55% | 31.91% | -52.93% | -15.98% |
| Sale of Property, Plant, and Equipment | -- | -- | 803.54% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.52% | -29.19% | 55.81% | -23.06% | 71.67% |
| Cash from Investing | 32.49% | -260.31% | 40.35% | -55.68% | -14.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.64% | 0.11% | 60.66% | -926.12% | 72.92% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 66.50% | 39.49% | -30.57% | 31.82% | -19.15% |
| Cash from Financing | 547.51% | 25.00% | 30.70% | -95.09% | -18.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 155.61% | 4,552.45% | -100.52% | 282.85% | -237.45% |